Clinical features and long-term prognosis of Crohn's disease in Korea

References

• Yang SK, Yun S, Kim JH, Park JY, Kim HY, Kim YH, Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study. Inflamm Bowel Dis 2008;14:542–9.
   PubMed Web of Science ®Google Scholar
• Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000;43:S85–93.
   Web of Science ®Google Scholar
• Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 2001;7:260–70.
   PubMed Web of Science ®Google Scholar
• Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008;103:3167–82.
   PubMed Web of Science ®Google Scholar
• Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004;10:646–51.
   PubMedGoogle Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599–603.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603–6.
   PubMed Web of Science ®Google Scholar
• Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925–8.
   PubMed Web of Science ®Google Scholar
• Croucher PJ, Mascheretti S, Hampe J, Huse K, Frenzel H, Stoll M, Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 2003;11:6–16.
   PubMed Web of Science ®Google Scholar
• Leong RW, Armuzzi A, Ahmad T, Wong ML, Tse P, Jewell DP, NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003;17:1465–70.
   PubMed Web of Science ®Google Scholar
• Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86–91.
   PubMed Web of Science ®Google Scholar
• Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A, IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 2007;132:1657–64.
   PubMed Web of Science ®Google Scholar
• Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, Reid J, Abkevich V, IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol 2007;102:2754–61.
   PubMed Web of Science ®Google Scholar
• Amre DK, Mack D, Israel D, Morgan K, Lambrette P, Law L, Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children. Am J Gastroenterol 2008;103:615–20.
   PubMed Web of Science ®Google Scholar
• Glas J, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population. Am J Gastroenterol 2008;103:682–91.
   PubMed Web of Science ®Google Scholar
• Weersma RK, Zhernakova A, Nolte IM, Lefebvre C, Rioux JD, Mulder F, ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands. Am J Gastroenterol 2008;103:621–7.
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Onouchi Y, Takazoe M, Kubo M, Nakamura Y, Hata A. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J Hum Genet 2007;52:575–83.
   PubMed Web of Science ®Google Scholar
• Yang SK, Park M, Lim J, Park SH, Ye BD, Lee I, Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans. Inflamm Bowel Dis 2009;15:1385–90.
   PubMed Web of Science ®Google Scholar
• Yang SK, Lim J, Chang HS, Lee I, Li Y, Liu J, Association of TNFSF15 with Crohn's disease in Koreans. Am J Gastroenterol 2008;103:1437–42.
   PubMed Web of Science ®Google Scholar
• Yamazaki K, McGovern D, Ragoussis J, Paolucci M, Butler H, Jewell D, Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005;14:3499–506.
   PubMed Web of Science ®Google Scholar
• Tremelling M, Berzuini C, Massey D, Bredin F, Price C, Dawson C, Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population. Inflamm Bowel Dis 2008;14:733–7.
   PubMed Web of Science ®Google Scholar
• Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690–7.
   PubMed Web of Science ®Google Scholar
• Molinie F, Gower-Rousseau C, Yzet T, Merle V, Grandbastien B, Marti R, Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988–1999). Gut 2004;53:843–8.
   Google Scholar
• Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006;101:1559–68.
   PubMed Web of Science ®Google Scholar
• Jacobsen BA, Fallingborg J, Rasmussen HH, Nielsen KR, Drewes AM, Puho E, Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978–2002. Eur J Gastroenterol Hepatol 2006;18:601–6.
   PubMed Web of Science ®Google Scholar
• Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology 1998;114:1161–8.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Yang SK, Byeon JS, Myung SJ, Chang HS, Hong SS, Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease. Endoscopy 2006;38:592–7.
   PubMedGoogle Scholar
• Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439–44.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749–53.
   PubMed Web of Science ®Google Scholar
• Hanauer SB. Crohn's disease: step up or top down therapy. Best Pract Res Clin Gastroenterol 2003;17:131–7.
   PubMed Web of Science ®Google Scholar
• Travis SP, Stange EF, Lémann M, Oresland T, Chowers Y, Forbes A, European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006;55(Suppl 1):16–35.
   PubMed Web of Science ®Google Scholar
• Wolfe RA. The standardized mortality ratio revisited: improvements, innovations, and limitations. Am J Kidney Dis 1994:24:290–7.
   PubMed Web of Science ®Google Scholar
• Park SH, Kim YM, Yang SK, Kim SH, Byeon JS, Myung SJ, Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis 2007;13:278–83.
   PubMed Web of Science ®Google Scholar
• Ghosh P. Tuberculosis of the gastrointestinal tract. In: Allan RN, Rhodes JM, Hanauer SB, Keighley MRB, Alexander-Williams M, Fazio VW, editors. Inflammatory bowel diseases. 3rd ed. New York: Churchill Livingstone; 1997. pp. 391–8.
   Google Scholar
• Kim CG, Kim JW, Kim HD, Kim SG, Kim JS, Jung HC, Clinical features of Crohn's disease in Korea. Korean J Gastroenterol 2002;40:173–80.
   Google Scholar
• Park JB, Yang SK, Myung SJ, Byeon JS, Lee YJ, Lee GH, Clinical characteristics at diagnosis and course of Korean patients with Crohn's disease. Korean J Gastroenterol 2004;43:8–17.
   PubMedGoogle Scholar
• Tonghua L, Guozong P, Minzhang C. Crohn's disease: clinicopathologic manifestations and differential diagnosis from enterocolonic tuberculosis. Chinese Med J 1981;94:431–40.
   PubMedGoogle Scholar
• American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 2003;125:1503–7.
   PubMed Web of Science ®Google Scholar
• Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000;231:38–45.
   PubMed Web of Science ®Google Scholar
• Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007;13:481–9.
   PubMed Web of Science ®Google Scholar
• Solberg IC, Vatn MH, Høie O, Stray N, Sauar J, Jahnsen J, Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007;5:1430–8.
   PubMed Web of Science ®Google Scholar
• Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54:237–41.
   PubMed Web of Science ®Google Scholar
• Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut 2009;58:492–500.
   PubMed Web of Science ®Google Scholar